Search
for
Sort by
Research 121–150 of 1000+
- Malt1 Protease Is Critical in Maintaining Function of Regulatory T Cells and May Be a Therapeutic Target for Antitumor Immunity
- Identifying molecular targets for reverse aging using integrated network analysis of transcriptomic and epigenomic changes during aging
- Immortalized human hair follicle-derived mesenchymal-like stromal cells for the long-term production of scalable Immunomodulatory and regenerative secretome
- Phospholipase A2 in skin biology: new insights from gene-manipulated mice and lipidomics
- Alopecia Areata: Pathogenesis, Diagnosis, and Therapies
- Lactate in skin homeostasis: metabolism, skin barrier, and immunomodulation
- Cellular and molecular mechanisms of repair in acute and chronic wound healing
- DKK1 Mediated Inhibition of Wnt Signaling in Postnatal Mice Leads to Loss of TEC Progenitors and Thymic Degeneration
- The Multi-Faceted Role of Gut Microbiota in Alopecia Areata
- Bioinformatic analysis of gene expression data reveals Src family protein tyrosine kinases as key players in androgenetic alopecia
- Nano-pulse stimulation™ therapy (NPS™) is superior to cryoablation in clearing murine melanoma tumors
- Enhancing Cancer Therapy with Hyperthermia: Synergistic Effects with Natural Compounds and Conventional Treatments
- Transcriptome Analysis Reveals an Inhibitory Effect of Dihydrotestosterone-Treated 2D- and 3D-Cultured Dermal Papilla Cells on Hair Follicle Growth
- Proteolysis‐targeting chimeras in cancer therapy: Targeted protein degradation for next‐generation treatment
- Author response: Deletion of the MAD2L1 spindle assembly checkpoint gene is tolerated in mouse models of acute T-cell lymphoma and hepatocellular carcinoma
- Decision letter: Deletion of the MAD2L1 spindle assembly checkpoint gene is tolerated in mouse models of acute T-cell lymphoma and hepatocellular carcinoma
- Protein S-Palmitoylation as Potential Therapeutic Target for Dermatoses
- Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force “Dermatology for Cancer Patients” International Study
- Understanding the Role of Type I Interferons in Cutaneous Lupus and Dermatomyositis: Toward Better Therapeutics
- Emerging Strategies in Smart Nano-PROTAC for Stimuli-Responsive Protein Degradation and Precision Cancer Therapy
- Internal peacekeepers and external mediators: A new model of peripheral immune tolerance involving regulatory T cells and mesenchymal stem cells
- Microneedle Arrays Combined with Nanomedicine Approaches for Transdermal Delivery of Therapeutics
- Targeted protein degradation of Wnt/β-catenin signaling pathway: an effective strategy for cancer therapy
- The TRPM5 Antagonist Triphenylphosphine Oxide Increases Sebaceous Lipogenesis and Modulates Immune Phenotype of Human Sebocytes in a TRPM5‐Independent Manner
- Spironolactone and XPB: An Old Drug with a New Molecular Target
- Group IID, IIE, IIF and III secreted phospholipase A2s
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- FOXP3 <sup>+</sup> regulatory T cells and age‐related diseases
- Immunomodulatory properties of mesenchymal stromal/stem cells: The link with metabolism
- LB1034 Meta-analysis of scalp transcriptome defines alopecia areata subtypes and molecular response to four (4) treatments with jak inhibiting properties